Inventor · disambiguated record
Michael John Wright
Also filed as: WRIGHT MICHAEL JOHN
15 granted patents·8 pending applications·83 citations·filing 2010–2023
92Inventor score
Top patents by PatentIndex Score
23 records- 0197US10590197B2Antibody molecules which bind CD22UCB BIOPHARMA SPRL·Filed 2016·Granted Mar 17, 2020·14 cites·7 claims
- 0296US10358493B2Bispecific format suitable for use in high-through-put screeningUCB BIOPHARMA SPRL·Filed 2015·Granted Jul 23, 2019·14 cites·9 claims
- 0393US10618957B2Antibody molecules which bind CD79UCB BIOPHARMA SPRL·Filed 2016·Granted Apr 14, 2020·9 cites·12 claims
- 0493US10370447B2Molecules with specificity for CD79 and CD22UCB BIOPHARMA SPRL·Filed 2015·Granted Aug 6, 2019·15 cites·11 claims
- 0592US11807680B2Gremlin-1 crystal structure and inhibitory antibodyUCB Biopharma SRL·Filed 2021·Granted Nov 7, 2023·3 cites·4 claims
- 0691US11472879B2Antibody molecules which bind CD22UCB Biopharma SRL·Filed 2020·Granted Oct 18, 2022·2 cites·20 claims
- 0790US10774152B2Molecules with specificity for CD45 and CD79UCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·5 cites·12 claims
- 0889US10947304B2Gremlin-1 antibodyUCB Biopharma SRL·Filed 2017·Granted Mar 16, 2021·6 cites·12 claims
- 0988US10774157B2Multispecific antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Sep 15, 2020·5 cites·17 claims
- 1087US11261252B2Molecules with specificity for CD79 and CD22UCB Biopharma SRL·Filed 2019·Granted Mar 1, 2022·2 cites·10 claims
- 1187US10618979B2Multispecific antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Apr 14, 2020·8 cites·11 claims
- 1282US12473355B2Gremlin-1 crystal structure and inhibitory antibodyUCB Biopharma SRL·Filed 2023·Granted Nov 18, 2025·0 cites·17 claims
- 1379US12331117B2Antibody molecules which bind CD22UCB Biopharma SRL·Filed 2022·Granted Jun 17, 2025·0 cites·20 claims
- 1471US2023287134A1Antibody molecules which bind cd45UCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 1564US2019322739A1Bispecific format suitable for use in high-through-put screeningUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 1658US11692041B2Antibody molecules which bind CD45UCB BIOPHARMA SPRL·Filed 2016·Granted Jul 4, 2023·0 cites·14 claims
- 1753US2019359713A1Molecules with specificity for cd45 and cd79UCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 1852US2021262024A1Polynucleotide duplex probe moleculeUCB Biopharma SRL·Filed 2019·Application pending·0 cites
- 1950US2019031752A1Method for Producing AntibodiesUCB PHARMA SA·Filed 2018·Application pending·0 cites
- 2050US2023176071A1Arrays and methods for identifying binding sites on a proteinUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 2142US2021301012A1Proteins and UsesUCB BIOPHARMA SPRL·Filed 2017·Application pending·0 cites
- 2241US2011313138A1Method for Producing ProteinsSTEPHENS PAUL EDWARD·Filed 2010·Application pending·0 cites
- 2335US11286312B2Multispecific antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Mar 29, 2022·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Michael John Wright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →